Examkin

Soru

Zorluk: OrtaInfectious Diseases

A 42-year-old man is evaluated in the hospital on day 3 of admission for community-acquired pneumonia. He initially presented with a productive cough, high fever, and shortness of breath. Chest radiography on admission showed a right lower lobe infiltrate. He was empirically started on intravenous ceftriaxone and azithromycin. Blood and sputum cultures obtained on admission have now grown Streptococcus pneumoniae. Susceptibility testing reveals the isolate is highly susceptible to penicillin (minimum inhibitory concentration < 0.06 mcg/mL), amoxicillin, ceftriaxone, and levofloxacin. Today, his temperature is 37.0 C (98.6 F), blood pressure is 120/78 mm Hg, pulse is 78/min, and respiratory rate is 14/min. His oxygen saturation is 97% on ambient air. He is tolerating a regular diet and reports feeling much better. Which of the following is the most appropriate next step in management?

  1. A
    Continue intravenous ceftriaxone and azithromycin
  2. B
    Transition to oral levofloxacin
  3. Transition to oral amoxicillinCevap
  4. D
    Transition to oral amoxicillin-clavulanate
  5. E
    Transition to oral amoxicillin and azithromycin

Cevap

Transition to oral amoxicillin
The most appropriate next step in management is transitioning to oral amoxicillin. This patient was admitted with community-acquired pneumonia (CAP) and empirically treated with a standard regimen of a beta-lactam (ceftriaxone) and a macrolide (azithromycin). On hospital day 3, he meets the criteria for clinical stability: he is afebrile, hemodynamically stable, off supplemental oxygen, and able to tolerate oral intake. When clinical stability is achieved, patients should be transitioned from intravenous to oral antibiotics. Furthermore, blood and sputum cultures identified Streptococcus pneumoniae that is highly susceptible to penicillin (MIC < 0.06 mcg/mL). According to principles of antibiotic stewardship, empiric broad-spectrum therapy should be de-escalated to the narrowest effective agent. For penicillin-susceptible S. pneumoniae, high-dose oral amoxicillin is the drug of choice because it provides excellent targeted coverage without unnecessarily disrupting normal gut flora.

Adım Adım Çözüm

1
Evaluate the patient's clinical stability for an intravenous-to-oral transition.
The patient is afebrile, hemodynamically stable, has normal oxygen saturation on ambient air, and is tolerating a regular diet.
Clinical stability indicates that the patient is ready to step down from intravenous to oral antibiotics, reducing hospital length of stay and risk of catheter-related complications.
2
Analyze the culture and susceptibility results to identify the optimal targeted therapy.
Cultures grew Streptococcus pneumoniae that is highly susceptible to penicillin and amoxicillin.
Empiric broad-spectrum therapy must be narrowed to targeted therapy once a causative pathogen and its susceptibilities are identified, in accordance with antibiotic stewardship principles.
3
Select the most appropriate narrow-spectrum oral antibiotic.
Oral amoxicillin is selected over broader options like fluoroquinolones or combination therapies.
Amoxicillin is the preferred narrow-spectrum oral beta-lactam for fully susceptible S. pneumoniae, avoiding the unnecessary broad-spectrum coverage.

Anahtar Kavram

In patients hospitalized with community-acquired pneumonia who achieve clinical stability and have a confirmed bacterial isolate, empiric broad-spectrum intravenous antibiotics should be de-escalated to narrow-spectrum targeted oral therapy.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Infectious Diseases

Bu konudan daha fazla soru